论文信息 - Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing. - 字舞流文

Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing.

Theodore A. Martinot | Yongxin Han | N. Solban | X. Fradera | Karin M. Otte | Hua Zhou | C. Lesburg | J. Miller | A. Pasternak | D. J. Bennett | J. Qi | Z. Song | A. Bass | Jingjun Yin | A. Achab | S. Vincent | Q. Pu | Kun-Lin Liu | Baoqiang Wan | Li-cheng Song | Ian Knemeyer | D. Sloman | Meredeth A. McGowan | B. Hopkins | Hongjun Zhang | B. Zamlynny | Derun Li | Indu Bharathan | Catherine White | N. Sciammetta | Craig R Gibeau | Heidi Ferguson | Huan Zhang | Suzanne DAddio | E. Freeland | B. Ykoruk | Catherine Hilliard | Jude Ferraro | Jinting Zhai